APA (7th ed.) Citation

L, B., V, M. D. P., JM, M., EI, L., P, U., Y, R. D. H., . . . MA, P. (2025). Universal administration of nirsevimab in infants: An analysis of hospitalisations and paediatric intensive care unit admissions for RSV-associated lower respiratory tract infections. European journal of pediatrics, 184(6), 345. https://doi.org/10.1007/s00431-025-06125-5

Chicago Style (17th ed.) Citation

L, Bermúdez-Barrezueta, et al. "Universal Administration of Nirsevimab in Infants: An Analysis of Hospitalisations and Paediatric Intensive Care Unit Admissions for RSV-associated Lower Respiratory Tract Infections." European Journal of Pediatrics 184, no. 6 (2025): 345. https://doi.org/10.1007/s00431-025-06125-5.

MLA (9th ed.) Citation

L, Bermúdez-Barrezueta, et al. "Universal Administration of Nirsevimab in Infants: An Analysis of Hospitalisations and Paediatric Intensive Care Unit Admissions for RSV-associated Lower Respiratory Tract Infections." European Journal of Pediatrics, vol. 184, no. 6, 2025, p. 345, https://doi.org/10.1007/s00431-025-06125-5.